Blue Water Life Science Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-25,800
Closed -$13.7M 9
2023
Q4
$13.7M Buy
+25,800
New +$12.5M 12% 4
2022
Q1
Sell
-78,300
Closed -$52.2M 15
2021
Q4
$52.2M Hold
78,300
15.98% 2
2021
Q3
$44.7M Buy
78,300
+15,300
+24% +$8.4M 14.55% 3
2021
Q2
$31.8M Buy
63,000
+43,867
+229% +$20.7M 11.96% 4
2021
Q1
$8.73M Buy
19,133
+4,533
+31% +$2.16M 4.27% 8
2020
Q4
$6.8M Buy
+14,600
New +$6.85M 3.99% 11

Other funds holding TMO

Blue Water Life Science Advisors's TMO Position: Q1 2024 in Review

Blue Water Life Science Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 25,800 shares — an estimated $13.7M sold.

Blue Water Life Science Advisors first reported a position in TMO in Q4 2020 and held it in 6 quarters. The position peaked at $52.2M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Blue Water Life Science Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 25,800 Thermo Fisher Scientific shares in Q1 2024, an estimated $13.7M.
  • Blue Water Life Science Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 6 quarters.
  • Blue Water Life Science Advisors's Thermo Fisher Scientific position peaked at $52.2M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2024, filed 15 May 2024.